Adverse events through 24 weeks in the subset of WOCBP (studies GS-US-320-0110 and GS-US-320-0108; week 96 integrated safety analysis set; reference 21).

NIAID Data Ecosystem30

Summary of treatment emergent adverse events (TEAE), overall and by study arm.

临床试验安全性

药物不良反应监测

Summary of treatment emergent adverse events (TEAE), overall and by study arm.

NIAID Data Ecosystem20

Articles meeting inclusion criteria by measured patient outcomes and findings (n = 20).

患者结局分析

临床研究系统综述

Articles meeting inclusion criteria by measured patient outcomes and findings (n = 20).

NIAID Data Ecosystem40

Unsafe testosterone-based dosing regimen of androgen deprivation therapy in patients with locally advanced or metastatic prostate cancer: a prematurely ended randomized controlled trial (MIDAS-trial)

前列腺癌雄激素治疗

临床试验安全性

Unsafe testosterone-based dosing regimen of androgen deprivation therapy in patients with locally advanced or metastatic prostate cancer: a prematurely ended randomized controlled trial (MIDAS-trial)

NIAID Data Ecosystem20

Details of patient deaths during study period.

资源简介：

相关数据集